Wockhardt Share Price
(WOCKPHARMA)
₹1155.5
as on 04:01PM, 28 Feb 2025
Wockhardt Performance
Day's Low
Day's High
₹1,110.05Day's Price Range₹1,186.752 Week's Low
52 Week's High
₹490.1552-Week Price Range₹1,679.9
| Returns % | |
| 1 Month Return | -25.86 % |
| 3 Month Return | -19.07 % |
| 1 Year Return | + 88.27 % |
| Market Stats | |
| Previous Close | ₹1,168.45 |
| Open | ₹1,150.05 |
| Volume | 11.39L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹18,773.68Cr |
Wockhardt Key Statistics
P/E Ratio
-87.87
PEG Ratio
-4.06
Market Cap
₹18,773.68 Cr
P/B Ratio
5
EPS
-30.65
Dividend Yield
0Sector
Pharmaceuticals
ROE
0Wockhardt Mutual Fund Holdings
Key events for Wockhardt Ltd
Wockhardt Develops Novel Drug for Resistant Infections - 22 Feb, 2025
Wockhardt's Dr. Sachin S Bhagwat announced the successful development of WCK 5222, a novel treatment for pan-drug resistant Gram-negative infections, saving over 45 lives. This breakthrough is expected to transform treatment approaches for severe infections.Wockhardt's Khorakiwala Comments on US Tariffs - 18 Feb, 2025
Habil Khorakiwala, founder chairman of Wockhardt Ltd., expressed that US tariffs on Indian pharmaceuticals will ultimately increase costs for US consumers, but he remains unconcerned.Wockhardt Reports Strong Sales Growth Despite Loss - 12 Feb, 2025
Wockhardt's standalone net sales for December 2024 reached Rs 325 crore, up 12.85% YoY. Despite a quarterly net loss of Rs 22 crore, EBITDA surged 126.67%. The stock has shown impressive returns of 46.46% over six months and 232.36% over twelve months.Wockhardt Reports Mixed Financial Performance and Strategic Changes - 11 Feb, 2025
Wockhardt's DII holding increased to 9.82%, but sales dropped from Rs 3,566 cr in FY19 to Rs 2,798 cr in FY24. The company is restructuring its U.S. operations, aiming for cost savings and expanding into vaccines. Despite losses growing to Rs 472 cr in FY24, EBITDA improved to Rs 91 cr. The share price surged 414% over five years, currently at Rs 1,635.Wockhardt Reports Strong Q3 Recovery with Profit - 07 Feb, 2025
Wockhardt Ltd. returned to profitability in Q3FY25 with a net profit of ₹20 crore, a significant recovery from last year's loss. Revenue increased by 3% to ₹721 crore, while EBITDA surged 246% to ₹128 crore, indicating improved operational efficiency. Despite initial gains, shares faced profit booking, closing down nearly 3%.Wockhardt's Zaynich Achieves Breakthrough in Trials - 31 Jan, 2025
Wockhardt Ltd's antibiotic Zaynich demonstrated a 96.8% clinical cure rate in a Phase III trial for complicated urinary tract infections, marking a significant milestone. The company plans to file for regulatory approvals with the US FDA and EMA, highlighting its commitment to addressing antibiotic resistance.Wockhardt Ltd Shows Potential for Rebound - 30 Jan, 2025
Wockhardt Ltd is experiencing strong support levels and positive RSI divergence, indicating a potential rebound in stock performance. Market participants are optimistic about its recovery.
Insights on Wockhardt Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, WOCKPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 7.09% to 7.13% in Dec 2024 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 34.39% to 34.53% in Dec 2024 quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, WOCKPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Price Rise
In the last 1 year, WOCKPHARMA stock has moved up by 88.3%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -22.0 Cr → 14.0 Cr (in ₹), with an average increase of 257.1% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 49.09% of holdings in Dec 2024 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 6.61% to 6.54% in Dec 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 818.0 Cr → 729.0 Cr (in ₹), with an average decrease of 10.9% per quarter
Wockhardt Financials
Index Inclusions
Wockhardt Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 49.09% | 0.00 | |
| Foreign Institutions | 6.54% | ||
| Mutual Funds | 7.13% | 0.58 | |
| Retail Investors | 34.53% | 0.40 | |
| Others | 2.71% |
Wockhardt Key Indicators
Wockhardt Valuation
Wockhardt in the last 5 years
Lowest (-125.67x)
February 5, 2025
Today (-87.87x)
February 28, 2025
Industry (50.30x)
February 28, 2025
Highest (12.70x)
May 26, 2021
Wockhardt Earnings and Dividends
Wockhardt Ltd Earnings Results
Wockhardt Ltd’s net profit jumped 116.87% since last year same period to ₹14Cr in the Q3 2024-2025. On a quarterly growth basis, Wockhardt Ltd has generated 163.64% jump in its net profits since last 3-months.
Read More about Earnings ResultsWockhardt Ltd Dividends November,2016
In the quarter ending September 2016, Wockhardt Ltd has declared dividend of ₹10 - translating a dividend yield of 0.87%.
Read More about Dividends
Wockhardt Technicals Summary
Bearish
Neutral
Bullish
Wockhardt Ltd is currently in a Bearish trading position according to technical analysis indicators.
Wockhardt Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹18,773.68 Cr | 61.73% | 0.77 | -₹472 Cr | ₹2,798 Cr | |
| BUY | ₹30,922.01 Cr | 124.15% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
| BUY | ₹14,380.01 Cr | 22.54% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
| NA | ₹3,647.30 Cr | -4.06% | 0.79 | -₹388 Cr | ₹75 Cr | |
| BUY | ₹12,588.35 Cr | 35.07% | 0.68 | ₹218 Cr | ₹1,296 Cr |
About Wockhardt
Share Price: ₹1155.50 per share as on 28 Feb, 2025 04:01 PM
Market Capitalisation: ₹18,773.68Cr as of today
Revenue: ₹721.00Cr as on December 2024 (Q4 24)
Net Profit: ₹20.00Cr as on December 2024 (Q4 24)
Listing date: 23 Feb, 2000
Chairperson Name: H F Khorakiwala
| Organisation | Wockhardt |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Wockhardt Ltd
What is Wockhardt Ltd price today?
Wockhardt Ltd share price today stands at ₹1155.5, Open: ₹1150.05, Previous Close: ₹1168.45, High: ₹1186.7, Low: ₹1110.05, 52 Week High: ₹1679.9, 52 Week Low: ₹490.15.
How to Buy Wockhardt Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Wockhardt Ltd shares
Is Wockhardt Ltd listed on NSE?
Wockhardt Ltd is listed on NSE
Is Wockhardt Ltd listed on BSE?
Wockhardt Ltd is listed on BSE
What are today's High and Low prices of Wockhardt Ltd?
- Today's highest price of Wockhardt Ltd is ₹1186.7.
- Today's lowest price of Wockhardt Ltd is ₹1110.05.
What are today's traded volumes of Wockhardt Ltd?
Today's traded volume of Wockhardt Ltd(WOCKPHARMA) is 11.39L.
What is today's market capitalisation of Wockhardt Ltd?
Today's market capitalisation of Wockhardt Ltd(WOCKPHARMA) is ₹18773.68Cr.
What is the 52 Week High and Low Range of Wockhardt Ltd?
How much percentage Wockhardt Ltd is down from its 52 Week High?
Wockhardt Ltd (WOCKPHARMA) share price is ₹1155.5. It is down -31.22% from its 52 Week High price of ₹1679.9
How much percentage Wockhardt Ltd is up from its 52 Week low?
Wockhardt Ltd (WOCKPHARMA) share price is ₹1155.5. It is up 135.74% from its 52 Week Low price of ₹490.15
What are the historical returns of Wockhardt Ltd?
What is the PE ratio of Wockhardt Ltd today?
PE Ratio of Wockhardt Ltd is -87.87
PE ratio = Wockhardt Ltd Market price per share / Wockhardt Ltd Earnings per share